New Market Study Published: Cavadis B.V. - Product Pipeline Analysis
Cavadis B.V. (Cavadis) is a biomedical company operating in the field of cardiovascular risk assessment. It develops prognostic tests to identify patients at risk of cardiovascular disease. The Cavadis pipeline focuses on a series of novel biomarkers in various phases of development. It comprises of individual markers and multi-marker panels for developing prognostic tests for cardiovascular indications, which include stroke, myocardial infarction, and peripheral artery disease. Currently, the company is developing CAV?RISK C?D, a blood-based prognostic assay to identify patients...
View full press release